Glutaminyl transpeptidase 200 U/L, which is about 5 times higher than the normal value, is more serious and usually suggests hepatobiliary diseases such as cholecystitis, viral hepatitis, cirrhosis and hepatocellular carcinoma.
Glutaminyl transpeptidase is mainly distributed in the cytoplasm of hepatocytes and bile duct epithelial cells, and is a commonly used clinical indicator for assessing the overall condition of liver function. The level of glutaminyl transpeptidase in the serum of a normal person ranges from 0 to 40 U/L, and the test result shows that it is 200 U/L, which is elevated by about 5 times, and it is a more serious condition indicating that liver function is in an impaired state.
Elevated glutamyl transpeptidase is commonly seen in viral hepatitis, autoimmune hepatitis, drug-induced liver injury, alcoholic liver disease, fatty liver, cirrhosis, liver cancer, etc.; in addition, cholecystitis, gallbladder stones, etc. can also lead to significant elevation of glutamyl transpeptidase.
The test result shows that the glutamyl transpeptidase is 200U/L, the patient should consult the doctor in time, improve the relevant examination if necessary, clarify the cause of the disease and actively treat it.